Akebia：Akebia Therapeutics
Akebia Therapeutics
Akebia Therapeutics Inc (AKBA) 財報分析和股票健診
https://statementdog.com
Akebia Therapeutics, Inc.依法於2007年2月27日在特拉華州成立。該公司是一家致力於：基於缺氧誘導因子的新型生物性專有療法的研發，腎臟疾病患者所需產品商業化 ...
Akebia Therapeutics
https://hk.finance.yahoo.com
AKBA - Akebia Therapeutics, Inc. NasdaqCM - NasdaqCM 即時價格。貨幣為USD。 1.2200. -0.1100 (-8.27%). 收市：04:00PM EDT. 1.2900 +0.07 (+5.74%)
Akebia Therapeutics
https://tw.stock.yahoo.com
Akebia Therapeutics, Inc. · 成交1.2800 · 開盤1.2000 · 最高1.2900 · 最低1.1900 · 一年內最高1.8400 · 買進1.27 · EPS (TTM)-0.5200 · PE Ratio(TTM). - ...
Akebia Therapeutics
https://akebia.com
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Akebia Therapeutics
http://ir.akebia.com
Since our founding in 2007, Akebia (Nasdaq: AKBA) has been focused on achieving better outcomes for people with kidney disease. We are a leader in the renal ...
Press Releases
https://ir.akebia.com
Akebia Therapeutics to Present at H.C. Wainwright Global Investment Conference. September 5, 2023. Akebia Therapeutics Reports Inducement Grants Under ...